Insilico Medicine (“Insilico”), a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, today announced that the company's drug discovery team ...
An experimental therapy showed promise as treatment for an aggressively spreading type of colorectal cancer in preclinical models, according to ...
A type of dietary fiber called inulin, commonly used in health supplements and known to have certain anti-inflammatory properties, can ...
Appendiceal cancer (malignancies of the appendix, a small tissue pouch that is part of the gastrointestinal tract) is very rare, ...
An article published in Science Advances suggests that a type of cancer treatment known as immune checkpoint blockade may be beneficial in certain cases ...
Experiments involving animals and human cells conducted at the University of São Paulo (USP) in Brazil suggest that niclosamide, an ...
- Neflamapimod demonstrates that it reverses the neurodegenerative process in the basal forebrain cholinergic system in animal models - - ...
Credit: Source: Vall d'Hebron Institute of Oncology (VHIO). Published in Molecular Cancer Therapeutics*, a journal of the American Association ...
In a new study, researchers at Cedars-Sinai found that antibiotics have sex-specific effects on the gut microbiome makeup of male ...
BIRMINGHAM, Ala. – Small interfering RNAs, or siRNAs, hold promise to treat tumors, through their ability to specifically knock down ...
NEW YORK, May 24, 2022 --- Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, today announced its nomination of ...
BIRMINGHAM, Ala. – James Bibb, Ph.D., and colleagues have described a novel preclinical drug that could have the potential to ...
BOSTON – Massachusetts General Hospital (MGH) researchers have developed a novel treatment strategy that has the potential to bring the ...
New evidence from a zebrafish model of epilepsy may help resolve a debate into how seizures originate, according to Weill ...
New York, April 13, 2022/PRNewswire/-- Insilico Medicine(“Insilico”), a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company today announced that the ...
WASHINGTON, D.C. - Today, the U.S. Department of Energy (DOE) announced $1 million in funding for three awards to advance research and development (R&D) ...
Research focused on the bioactive components of the strawberry variety Romina has shown the ability of this food to delay ...
PHILADELPHIA — Chimeric antigen receptor (CAR) T cells can be remarkably effective in treating leukemias and lymphomas, but there are no ...
A synthetic viral vector and a novel surgical approach developed at Mass Eye and Ear has enabled efficient gene transfer ...
As part of our commitment to making a meaningful contribution to tobacco harm reduction, Imperial Brands continues to assess the ...
